New 5-FU Derivative EB-18 Shows Potency Against Resistant Cancers
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Researchers have engineered EB-18, a phosphonium-substituted derivative of the classic chemotherapy drug 5-fluorouracil that outperforms 5-FU and standard agents in...
Researchers used an aqueous extract of Malabar spinach to synthesize manganese dioxide nanoparticles that showed potent antibacterial, antioxidant, and anticancer...
A Swiss genomic study of muscle-invasive bladder cancer finds that oncogene amplifications, rather than tumor mutational burden or microsatellite instability,...
A new review in Molecular Cancer argues that extrachromosomal DNA acts as a dynamic epigenetic reprogramming platform that reshapes chromatin,...
Cancer screening experts argue that excessive caution in screening policy has cost thousands of lives and propose five principles for...
The phase 2 PEGASUS trial tested whether serial circulating tumor DNA measurements can safely guide de-escalation or escalation of adjuvant...
A leakage-aware, auditable computational framework trained on LINCS L1000 signatures identifies class I HDAC inhibitors, led by Mocetinostat, as top...
A radiation-free modified Baltimore conditioning regimen produced engraftment in all patients and survival outcomes comparable to the classical irradiation-based protocol...
A new study shows modified radiation lobectomy with yttrium-90 microspheres can shrink large liver tumors and grow the future liver...
A standardized single-stage workflow combining tumor resection with immediate CAD/CAM-assisted cranio-orbital reconstruction proved feasible, safe and reproducible in 34 patients...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine